I-Mab Biopharma
IMAB
$2.15
Share price
-6.11%
Change (1 day)
43.33%
Change (1 year)
Categories
Earnings for I-Mab Biopharma (IMAB)
Earnings in 2025 (TTM): -$41.3 Million USD
According to I-Mab Biopharma's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -$47.57 Million USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for I-Mab Biopharma from 2024 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -$41.3 Million | -13.18% |
| 2024 | -$47.57 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | -$18.16 Million | -56.03% | 🇺🇸 USA |
 OPKO Health
OPK | -$0.56 Million | -98.66% | 🇺🇸 USA |